In July 2009 Adam was diagnosed with neuroblastoma, a childhood cancer affecting around 100 children in the UK each year. Half of them, like Adam, are classified as high-risk. Despite an intensive treatment regimen, just 3 out of every 10 children with high-risk neuroblastoma make it to five years of remission. Once the disease returns there is little hope for long-term survival.

Adam never reached remission. Four years on from diagnosis, on the morning of 11 July 2013, Adam died of neuroblastoma. He was just nine years old.

Children with high-risk neuroblastoma desparately require better, and less toxic, treatments. Many of those who do survive will go on to develop other serious conditions caused by chemotherapy and radiation.

All monies raised here in memory of Adam will go to Solving Kids' Cancer to help fund research and new clinical trials here in the UK with the purpose of finding better treatments, saving more lives, and minimising harmful side-effects.